Strategic partnership Exactis Innovation collaborates with major data and oncology partners (e.g., Sophia Genetics) to enhance real-world evidence capabilities in Canada, signaling opportunities to co-sell or expand joint offerings to hospitals and health systems seeking integrated RWE solutions.

Niche market focus As a small non-profit focused on cancer survivorship and real-world data, Exactis presents a high-touch, specialized target for healthcare networks, research institutions, and CADTH program participants looking to accelerate evidence generation and decision support.

Global collaboration Existing and announced partnerships indicate receptivity to cross-border data sharing and multinational datasets, suggesting sales plays around interoperable data platforms, multi-site studies, and harmonized real-world evidence workflows.

Low-cost entry With a modest revenue base and a lean team, there may be opportunities for pilot projects, subscription-based access to RWE dashboards, or hosted analytics services that provide tangible ROI for partner hospitals without large upfront commitments.

Technology stack leverage People and processes can be accelerated by AWS, CMS-enabled sites, and lightweight web platforms; upsell potential exists for enterprise data integration, secure data pipelines, and enhanced analytics capabilities tailored to oncology RWE studies.